Rivia raises $15M
Rivia announced a Series A round of $15M on 18 March 2026. The company operates in HealthTech and is based in United Kingdom. It was founded by Erik Scalfaro, Co-Founder & CEO.
Founder
Erik Scalfaro
Co-Founder & CEO, Rivia
Outreach angles
- -Worked as Consultant and Analyst at IQVIA (the world's largest clinical research organization) from 2019 to 2022 before founding Rivia, giving him direct insider knowledge of the exact inefficiencies his platform solves.
- -Previously a Research Associate in Neuroimaging at EPFL and Patient Safety Associate at Novartis Pharma, with a scientific background that lends strong credibility when selling to pharma and biotech buyers.
- -Just raised $15M Series A led by Earlybird to launch Rivia Spark, an AI agent that converts natural language prompts into clinical-grade data visualizations for trial operators.
Signals
Series AAI-NativeB2BEnterpriseVertical SaaSRegulated IndustryDeep TechHiringVC-Backed
Round details
Company: Rivia
Domain: rivia.com
Amount: $15M
Stage: Series A
Industry: HealthTech
Country: United Kingdom
Announced: 18 March 2026
Other HealthTech raises
Recently funded in United Kingdom